Singapore markets closed

Novo Nordisk A/S (0TDD.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
96.29-0.24 (-0.25%)
At close: 05:24PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 349.16%
S&P500 52-week change 316.55%
52-week high 3105.68
52-week low 364.19
50-day moving average 398.05
200-day moving average 386.44

Share statistics

Avg vol (3-month) 317.61k
Avg vol (10-day) 36.1k
Shares outstanding 52.41B
Implied shares outstanding 6N/A
Float 83.31B
% held by insiders 10.01%
% held by institutions 18.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 37.07
Trailing annual dividend yield 37.33%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 320 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 35.11%
Operating margin (ttm)45.82%

Management effectiveness

Return on assets (ttm)21.57%
Return on equity (ttm)88.77%

Income statement

Revenue (ttm)214.49B
Revenue per share (ttm)47.73
Quarterly revenue growth (yoy)28.90%
Gross profit (ttm)148.51B
EBITDA 100.11B
Net income avi to common (ttm)75.31B
Diluted EPS (ttm)3.03
Quarterly earnings growth (yoy)56.00%

Balance sheet

Total cash (mrq)47.59B
Total cash per share (mrq)10.63
Total debt (mrq)26.54B
Total debt/equity (mrq)28.54%
Current ratio (mrq)0.82
Book value per share (mrq)20.77

Cash flow statement

Operating cash flow (ttm)106.46B
Levered free cash flow (ttm)63.8B